Boron
Active ingredient
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 1
- FDA reports (12 mo)
- 19
Overview
Plain-language summary, compiled from the cited regulatory records
Boron is a naturally occurring element. Its drug class and approved uses are not specified in the provided data [1].
In the past 12 months, there have been 19 adverse event reports associated with Boron [2]. The most frequently reported reactions include fatigue, headache, malaise, dermatitis, and dizziness [2].
Boron is available under various brand names [1].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | February 19, 2026 |
USUnited States· FDA
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [1].
Most-reported reactions to the US regulator (12 mo to June 4, 2026): 19 reports total. [2]
- Fatigue 3
- Headache 3
- Malaise 3
- Dermatitis 2
- Dizziness 2
- Feeling Abnormal 2
- Feeling Jittery 2
- Gastroenteritis Viral 2
- Insomnia 2
- Muscle Spasms 2
- Nasal Inflammation 2
Sources & citations
- [1]FDA DailyMed · 02e460fb-6beb-60… · revised February 19, 2026 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.